Overview Fundamentals API Earnings EOD API Sample Code Pricing

Enveric Biosciences Inc (ENVB NASDAQ) stock market data APIs

$0.4998 0.03(6.4%) as of July 19, 2024
Price chart is built with Anychart

Enveric Biosciences, Inc., a biotechnology company, engages in the development of small-molecule therapeutics for the treatment of anxiety, depression, and addiction disorders. Its lead product candidates are EB-002, an active metabolite of psilocybin, which is in preclinical development stage for the treatment of anxiety disorders; and EB-003 that is in preclinical development stage for the treatment mental health. The company also focuses on the development of cannabinoid conjugate molecules for the treatment of pain and cancer. Enveric Biosciences, Inc. is headquartered in Naples, Florida.

Enveric Biosciences Inc Financial Data Overview

4 095 K
7 954 K
35 405 K
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'ENVB',
Type: 'Common Stock',
Name: 'Enveric Biosciences Inc',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG000BBQ281',
CIK: '890821',
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: '2015-06-24',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: NULL,
IsDelisted: false,

Enveric Biosciences Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 35 405 K
  • EBITDA -13 722 174
  • Earnings Per Share -6.39
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Enveric Biosciences Inc Earnings via APIs

  • Latest Release 2024-05-15
  • EPS/Forecast -0.77

Get Enveric Biosciences Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?